Skip to main content

Advertisement

ADVERTISEMENT

videos

Lawrence Shulman, MD
Videos
10/16/2022
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical...
10/16/2022
Journal of Clinical Pathways
Lawrence Shulman, MD
Videos
10/16/2022
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical Pathways Congress, Lawrence Shulman, MD, discusses the need for having critical systems in place and unencumbered access to patient data to achieve optimal care, and emphasizes the role that coordinated clinical...
At the 2022 Oncology Clinical...
10/16/2022
Journal of Clinical Pathways
Sayeh Lavasani, MD, MS, FRCPC
Videos
10/16/2022
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC,...
10/16/2022
Journal of Clinical Pathways
Sayeh Lavasani, MD, MS, FRCPC
Videos
10/16/2022
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC,...
10/16/2022
Journal of Clinical Pathways
Sayeh Lavasani, MD, MS, FRCPC
Videos
10/16/2022
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC, highlights the financial advantage of pathways, stating that clinical pathway utilization can save up to 35% in the cost of treatment in breast cancer, while providing up-to-date, evidence-based treatment...
Sayeh Lavasani, MD, MS, FRCPC,...
10/16/2022
Journal of Clinical Pathways
Margaret Rehayem
Videos
10/15/2022
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Margaret Rehayem
Videos
10/15/2022
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Margaret Rehayem
Videos
10/15/2022
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, MA, National Alliance of Healthcare Purchaser Coalitions, takes the employer perspective on value-based care with technology advancements and how to help an employer look at...
At the 2022 Oncology Clinical...
10/15/2022
Journal of Clinical Pathways
Tatjana Kolevska, MD
Videos
10/15/2022
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser...
10/15/2022
Journal of Clinical Pathways
Tatjana Kolevska, MD
Videos
10/15/2022
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to...
Tatjana Kolevska, MD, Kaiser...
10/15/2022
Journal of Clinical Pathways

Advertisement